View in EDS

Modified study designs to expand treatment options in personalised oncology: a multistakeholder view.

Saved in:
Bibliographic Details
Title: Modified study designs to expand treatment options in personalised oncology: a multistakeholder view.
Authors: Le Tourneau C; Department of Drug Development and Innovation (D3i), Institut Curie, INSERM U900 Research Unit, Paris-Saclay University, Paris, France., André F; Institut Gustave Roussy, Paris, France., Helland Å; Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Mileshkin L; Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia., Minnaard W; Missie Tumor Onbekend, Amsterdam, Netherlands., Schiel A; Norwegian Medicines Agency, Oslo, Norway., Taskén K; Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Thomas DM; Garvan Institute of Medical Research, Darlinghurst, Australia., Veronese ML; Incyte International Biosciences Sàrl, Morges, Switzerland., Durán-Pacheco G; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Leyens L; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Rufibach K; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Thomas M; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Krämer A; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ) and Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany. Electronic address: a.kraemer@Dkfz-Heidelberg.de.
Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2023 Nov; Vol. 194, pp. 113278. Date of Electronic Publication: 2023 Aug 04.
Publication Type: Journal Article; Review
Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37820553
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Modified study designs to expand treatment options in personalised oncology: a multistakeholder view.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Le+Tourneau+C%22">Le Tourneau C</searchLink>; Department of Drug Development and Innovation (D3i), Institut Curie, INSERM U900 Research Unit, Paris-Saclay University, Paris, France.<br /><searchLink fieldCode="AU" term="%22André+F%22">André F</searchLink>; Institut Gustave Roussy, Paris, France.<br /><searchLink fieldCode="AU" term="%22Helland+Å%22">Helland Å</searchLink>; Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Mileshkin+L%22">Mileshkin L</searchLink>; Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Minnaard+W%22">Minnaard W</searchLink>; Missie Tumor Onbekend, Amsterdam, Netherlands.<br /><searchLink fieldCode="AU" term="%22Schiel+A%22">Schiel A</searchLink>; Norwegian Medicines Agency, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Taskén+K%22">Taskén K</searchLink>; Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Thomas+DM%22">Thomas DM</searchLink>; Garvan Institute of Medical Research, Darlinghurst, Australia.<br /><searchLink fieldCode="AU" term="%22Veronese+ML%22">Veronese ML</searchLink>; Incyte International Biosciences Sàrl, Morges, Switzerland.<br /><searchLink fieldCode="AU" term="%22Durán-Pacheco+G%22">Durán-Pacheco G</searchLink>; F. Hoffmann-La Roche Ltd, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Leyens+L%22">Leyens L</searchLink>; F. Hoffmann-La Roche Ltd, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Rufibach+K%22">Rufibach K</searchLink>; F. Hoffmann-La Roche Ltd, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Thomas+M%22">Thomas M</searchLink>; F. Hoffmann-La Roche Ltd, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Krämer+A%22">Krämer A</searchLink>; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ) and Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany. Electronic address: a.kraemer@Dkfz-Heidelberg.de.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229005373%22">European journal of cancer (Oxford, England : 1990)</searchLink> [Eur J Cancer] 2023 Nov; Vol. 194, pp. 113278. <i>Date of Electronic Publication: </i>2023 Aug 04.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science+Ltd%22">Elsevier Science Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9005373 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-0852 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209598049%22">09598049 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37820553
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ejca.2023.113278
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 113278
    Titles:
      – TitleFull: Modified study designs to expand treatment options in personalised oncology: a multistakeholder view.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Le Tourneau C
      – PersonEntity:
          Name:
            NameFull: André F
      – PersonEntity:
          Name:
            NameFull: Helland Å
      – PersonEntity:
          Name:
            NameFull: Mileshkin L
      – PersonEntity:
          Name:
            NameFull: Minnaard W
      – PersonEntity:
          Name:
            NameFull: Schiel A
      – PersonEntity:
          Name:
            NameFull: Taskén K
      – PersonEntity:
          Name:
            NameFull: Thomas DM
      – PersonEntity:
          Name:
            NameFull: Veronese ML
      – PersonEntity:
          Name:
            NameFull: Durán-Pacheco G
      – PersonEntity:
          Name:
            NameFull: Leyens L
      – PersonEntity:
          Name:
            NameFull: Rufibach K
      – PersonEntity:
          Name:
            NameFull: Thomas M
      – PersonEntity:
          Name:
            NameFull: Krämer A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2023 Nov
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1879-0852
          Numbering:
            – Type: volume
              Value: 194
          Titles:
            – TitleFull: European journal of cancer (Oxford, England : 1990)
              Type: main
ResultId 1